O

Oxford BioTherapeutics

45 employees

Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.

Basic info

Industry

biotechnology research

Sectors

Protein Target Discovery
Health Diagnostics
Biotechnology
Health Care
Antibody-Drug Conjugates
Immune-Oncology
Therapeutics
Proteomics
Genetics
Oncology
Cancer

Date founded

2004

Funding rounds raised

Total raised

$10M

from 11 investors over 11 rounds

O

Oxford BioTherapeutics raised undisclosed on November 19, 2018

Investors: Renaissance Capital Partners

O

Oxford BioTherapeutics raised undisclosed on July 29, 2018

Investors: Renaissance Capital Partners

O

Oxford BioTherapeutics raised $10M on January 26, 2017

Investors: Oxford Finance LLC

O

Oxford BioTherapeutics raised $1.1M on August 20, 2010

Investors: South East Growth Fund and -

O

Oxford BioTherapeutics raised $1.1M on March 23, 2010

Investors: South East Growth Fund

O

Oxford BioTherapeutics raised $1.2M on February 24, 2009

Investors: South East Growth Fund and -

O

Oxford BioTherapeutics raised $1.3M on August 15, 2008

Investors: -

O

Oxford BioTherapeutics raised $3.9M on January 4, 2007

Investors: South East Growth Fund and -

FAQ